Trials / Completed
CompletedNCT06136975
Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence
The Efficacy of Low-level Laser Therapy in Relieving Vaginal Dryness and Lower Urinary Tract Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are common for women. Low-level laser therapy (LLLT) was applied for wound healing, but there was no study regarding treatment effect of GSM and SUI. This retrospective study aims to assess the efficacy of LLLT in alleviating GSM and SUI.
Detailed description
Between September 2022 and August 2023, all women who received LLLT for GSM and SUI at the gynecologic outpatient clinic of a hospital were retrospectively reviewed. The treatment was once a week for eight weeks. Vaginal health index (VHI) and questionnaires before and after treatment for evaluation of lower urinary tract symptoms (LUTS) and quality of life are the outcome assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low-level laser therapy | The treatment was once a week for eight weeks. The patient was in a supine position. The gain medium of the laser was Gallium-Aluminum-Arsenide. The laser was introduced into vagina via a silicon vaginal probe inserted by a doctor for 30 minutes (wavelength 660nm, power density 18.17mW/cm2, energy density 0.018J/cm2s, total energy density 32.4J/cm2). |
Timeline
- Start date
- 2022-09-30
- Primary completion
- 2023-08-14
- Completion
- 2023-08-14
- First posted
- 2023-11-18
- Last updated
- 2023-11-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06136975. Inclusion in this directory is not an endorsement.